NASDAQ: BNGOBionano Genomics Inc Stock
$2.26-0.29 (-11.37%)
Updated Aug 9, 2022
BNGO Price
$2.26
Fair Value Price
$2.35
Market Cap
$655.72M
52 Week Low
$1.16
52 Week High
$6.28
P/E
-6.11x
P/B
2.3x
P/S
16.9x
PEG
N/A
Dividend Yield
N/A
Revenue
$23.32M
Earnings
-$105.81M
Gross Margin
16%
Operating Margin
-476.63%
Profit Margin
-453.7%
Debt to Equity
0.13
Operating Cash Flow
-$106M
Beta
0.96
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BNGO Overview
Zen Score
–
Industry Average (34)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BNGO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BNGO ($2.26) is undervalued by 3.78% relative to our estimate of its Fair Value price of $2.35 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
BNGO ($2.26) is not significantly undervalued (3.78%) relative to our estimate of its Fair Value price of $2.35 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BNGO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BNGO due diligence checks available for Premium users.
BNGO News
Valuation
BNGO fair value
Fair Value of BNGO stock based on Discounted Cash Flow (DCF)
Price
$2.26
Fair Value
$2.35
Undervalued by
3.78%
BNGO ($2.26) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BNGO ($2.26) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BNGO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
BNGO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-6.11x
Industry
36.23x
Market
32.55x
BNGO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.3x
Industry
4.32x
BNGO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BNGO's financial health
Profit margin
Revenue
$6.7M
Net Income
-$32.2M
Profit Margin
-482.1%
BNGO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BNGO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$321.6M
Liabilities
$36.8M
Debt to equity
0.13
BNGO's short-term assets ($216.29M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BNGO's short-term assets ($216.29M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BNGO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$28.3M
Investing
$31.2M
Financing
$203.0k
BNGO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BNGO vs Diagnostic & Research Stocks
Bionano Genomics Stock FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.